Arthur D. Little - information for the media

Welcome to the press section of Arthur D. Little. We put great emphasis on good relations with the media. In the press section, you will find the latest press releases, contact partners and our media echo showing you the most important publications in different countries. We would like to expressly invite the media to contact us if you have additional enquiries or need particular information.

Latest press releases

Healthcare UK, London - 31 August 2017

High hopes for funding low-priority drug trials

It’s no secret that big pharma invests billions in R&D each year, despite recent headlines bemoaning the cuts companies have made to their research budgets in recent years. This investment in exploratory-stage compounds has resulted in a robust pipeline of promising new therapies across a number of disease areas, which could save and improve millions of lives the world over. However, how many of these potential new drugs are being shelved indefinitely because of a lack of resources to fund costly and time-intensive clinical trials? In this article, Ben van der Schaaf at Arthur D. Little, discusses that although not every pipeline drug can get blockbuster funding, there are ways to breathe new life into neglected products.

Notes to Editors

Pharma Times

Search by keyword

Marketing & Communication Director

Francois Valraud
Chief Operating Officer
Arthur D. Little Services

+33 1 55 74 29 20

Article Toolbar

Navigation« previous article|next article »


| |Bookmark Arthur D. Little